Chemiluminescent Probes with Long‐Lasting High Brightness for In Vivo Imaging of Neutrophils. Issue 30 (1st June 2022)

• Record Type: Journal Article
• Authors: Huang, Jingsheng; Cheng, Penghui; Xu, Cheng; Liew, Si Si; He, Shasha; Zhang, Yan; Pu, Kanyi
• Is Part Of: Angewandte Chemie international edition. Volume 61:Issue 30(2022)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2022-06-01
• Subjects: Bioimaging -- Chemiluminescence Probe -- Neutrophils -- Reactive Oxygen Species; Chemistry -- Periodicals; 540
• DOI: 10.1002/anie.202203235
• Languages: English
• ISSNs: 1433-7851

Abstract

Abstract: Real‐time optical imaging of immune cells can contribute to understanding their pathophysiological roles, which still remains challenging. Current sensitive chemiluminophores have issues of short half‐lives and low brightness, limiting their ability for in vivo longitudinal monitoring of immunological processes. To tackle these issues, we report benzoazole‐phenoxyl‐dioxetane (BAPD)‐based chemiluminophores with intramolecular hydrogen bonding for in vivo imaging of neutrophils. Compared with the classical counterpart, chemiluminescence half‐lives and brightness of BAPDs in the aqueous solution are increased by ∼ 33‐ and 8.2‐fold, respectively. Based on the BAPD scaffold, a neutrophil elastase‐responsive chemiluminescent probe is developed for real‐time imaging of neutrophils in peritonitis and psoriasis mouse models. Our study provides an intramolecular hydrogen bonding molecular design for improving the performance of chemiluminophores in advanced imaging applications. Abstract : Ultrabright activatable chemiluminescent probes were synthesized which were equipped with intramolecular hydrogen bonding to prolong their half‐lives for in vivo imaging of neutrophils in peritonitis and psoriasis mouse models.